StonvexLoading…
StonvexCore line items from TOPP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.11M | $16.55M | $12.28M | $7.78M |
Operating Income | $-714.07K | $-7.38M | $-6.23M | $-2.00M |
Net Income | $-653.73K | $-7.34M | $-6.21M | $-2.06M |
EPS (Diluted) | $-0.03 | $-0.41 | $-0.36 | $-0.12 |
Total Assets | $10.25M | $11.00M | $10.71M | $12.26M |
Total Liabilities | $2.29M | $2.37M | $1.55M | $2.73M |
Cash & Equivalents | $836.17K | $1.20M | $463.35K | $1.49M |
Free Cash Flow OCF − CapEx | Not available | $-2.14M | $-2.60M | $-2.15M |
Shares Outstanding | 19.70M | 19.70M | 19.40M | 17.50M |